News and commentary from the endocrinology world
— News and commentary from the endocrinology world
September 8, 2026
• 2 min read
Men predisposed to androgenetic alopecia had a higher risk of hair loss when using GLP-1 drugs, a Mendelian randomization study suggested. (Journal of Investigative Dermatology)
Truveta data indicated a 19% increase in GLP-1 prescribing among eligible beneficiaries after the Medicare GLP-1 Bridge program was launched.
GLP-1 drugs like Wegovy and Ozempic are never out of the headlines for long.
GLP-1 receptor agonist therapy was associated with an increased risk for hair loss among adults with type 2 diabetes compared…
NEW YORK — GLP-1 receptor agonists offer dermatologic benefits but the same medications can leave patients grappling with several…
People taking GLP-1 drugs have a low risk of hair loss, which is significantly higher than for those on other diabetes…
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased…
Absolute risk of alopecia was low, however
